» Articles » PMID: 29920251

The Bayesian Adaptive Lasso Regression

Overview
Journal Math Biosci
Specialty Public Health
Date 2018 Jun 20
PMID 29920251
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Classical adaptive lasso regression is known to possess the oracle properties; namely, it performs as well as if the correct submodel were known in advance. However, it requires consistent initial estimates of the regression coefficients, which are generally not available in high dimensional settings. In addition, none of the algorithms used to obtain the adaptive lasso estimators provide a valid measure of standard error. To overcome these drawbacks, some Bayesian approaches have been proposed to obtain the adaptive lasso and related estimators. In this paper, we consider a fully Bayesian treatment for the adaptive lasso that leads to a new Gibbs sampler with tractable full conditional posteriors. Through simulations and real data analyses, we compare the performance of the new Gibbs sampler with some of the existing Bayesian and non-Bayesian methods. Results show that the new approach performs well in comparison to the existing Bayesian and non-Bayesian approaches.

Citing Articles

Decoding Alzheimer's Disease With Depression: Molecular Insights and Therapeutic Target.

Li Z, Guo H, Ge Y, Li X, Dong F, Zhang F J Cell Mol Med. 2025; 29(5):e70454.

PMID: 40074694 PMC: 11903198. DOI: 10.1111/jcmm.70454.


Multiomics-Based Deep Learning Prediction of Prognosis and Therapeutic Response in Patients With Extensive-Stage Small Cell Lung Cancer Receiving Chemoimmunotherapy: A Retrospective Cohort Study.

Nie F, Pei X, Du J, Shi W, Wang J, Feng L Int J Gen Med. 2025; 18:981-996.

PMID: 40026810 PMC: 11869764. DOI: 10.2147/IJGM.S506485.


Identification of biomarkers in Alzheimer's disease and COVID-19 by bioinformatics combining single-cell data analysis and machine learning algorithms.

Li J, Tao L, Zhou Y, Zhu Y, Li C, Pan Y PLoS One. 2025; 20(2):e0317915.

PMID: 39965013 PMC: 11835241. DOI: 10.1371/journal.pone.0317915.


Identification and validation of TSPAN13 as a novel temozolomide resistance-related gene prognostic biomarker in glioblastoma.

Wang H, Liu Z, Peng Z, Lv P, Fu P, Jiang X PLoS One. 2025; 20(2):e0316552.

PMID: 39903772 PMC: 11793784. DOI: 10.1371/journal.pone.0316552.


Comprehensive analysis reveals the tumor suppressor role of macrophage signature gene FCER1G in hepatocellular carcinoma.

Kong D, Zhang Y, Jiang L, Long N, Wang C, Qiu M Sci Rep. 2025; 15(1):3995.

PMID: 39893200 PMC: 11787346. DOI: 10.1038/s41598-025-88071-8.